University of California San Francisco
Give to UCSFUCSF experts discuss the current state of Alzheimer’s treatments and future therapies that may slow progression of the disease.
Through decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.
While we sleep, our brains process our daily actions to create motor memory, which makes physical acts such as throwing a basketball subconscious.
In a Q&A, UCSF’s Jason Nagata answers questions about the links between screen time and illnesses like OCD for children and teens.
For preteens, the odds of developing OCD over a two-year period increases for every hour they play video games or watch videos.
38 UCSF researchers rank in the top 1 percent for impact in their fields, according to a new analysis of research citations by science and intellectual property company Clarivate.
A low-cost, prenatal intervention benefits mothers’ mental health up to eight years later, a new UCSF study finds.
UCSF Experts Present Research at the Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference in San Francisco.
Risk of death or hospitalization from COVID-19 were found to be greater for patients with PTSD.
The brains of people with Down syndrome develop the same neurodegenerative tangles and plaques associated with Alzheimer’s disease and frequently demonstrate signs of the neurodegenerative disorder in their forties or fifties. A new study shows that these tangles and plaques are driven by the same amyloid beta (Aß) and tau prions as Alzheimer’s disease.